ROM Outcomes in Patients Undergoing a Primary TKA

Sponsor
University of Louisville (Other)
Overall Status
Completed
CT.gov ID
NCT04217486
Collaborator
(none)
158
1
2
15.8
10

Study Details

Study Description

Brief Summary

The goal of this prospective, randomized study is to compare the outcomes of patients undergoing primary TKA after photographing final knee range of motion immediately post-operatively and sharing these photographs with patients at their first follow-up appointment versus a group that does not see a photograph.

Condition or Disease Intervention/Treatment Phase
  • Other: Patient will be shown a photograph of their knee at 2 weeks postop
  • Other: Patient will not be shown a photograph of their knee at 2 weeks postop
N/A

Detailed Description

The goal of this prospective, randomized study is to compare the outcomes of patients undergoing primary total knee arthroplasty (TKA) after photographing final knee range of motion immediately postoperatively and sharing these photographs with patients at their first follow-up appointment versus a group that does not see a photograph. The knee will be photographed in maximum flexion and extension. The primary objectives will be to compare the range of motion of the operative knee at 2 weeks and 6 weeks postoperatively. In the investigator's institution, patients who have failed to achieve 90 degrees of flexion at a postoperative period of 6 weeks undergo manipulation of the knee under anesthesia (MUA). The investigators will also measure how many patients require MUA in the photograph group and non-photograph group. MUA will be performed if patients fail to achieve 90 degrees of flexion at 6 weeks post-op.

Study Design

Study Type:
Interventional
Actual Enrollment :
158 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Will Visual Affirmation of Knee Range of Motion (ROM) Affect Patient Outcomes in Patients Undergoing a Primary Total Knee Arthroplasty (TKA)? A Prospective, Randomized Study.
Actual Study Start Date :
Feb 4, 2020
Actual Primary Completion Date :
Sep 21, 2020
Actual Study Completion Date :
May 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: A - will be shown their photograph at 2 weeks post-operative.

40-50 arms: patients undergoing a unilateral, cementless primary TKA, secondary to osteoarthritis will be shown a photograph of their knee, photographed in maximum flexion and extension, at 2 weeks postoperatively.

Other: Patient will be shown a photograph of their knee at 2 weeks postop
Patients who undergo primary TKA surgery will then be shown a photograph of their knee at 2 weeks postoperative.

Active Comparator: B - will not be shown their photograph

40-50 arms: patients undergoing a unilateral, cementless primary TKA, secondary to osteoarthritis will not be shown a photograph of their knee, photographed in maximum flexion and extension, at 2 weeks postoperatively.

Other: Patient will not be shown a photograph of their knee at 2 weeks postop
Patients who undergo primary TKA surgery will not be shown a photograph of their knee at 2 weeks postoperative.

Outcome Measures

Primary Outcome Measures

  1. total length of hospital stay [outcome measure will be taken at 2 weeks postoperatively]

    total length of hospital stay as defined by number of days from date of surgery to date of discharge

  2. Knee Society Score [outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)]

    Knee Society Score. The score is on a scale from 0-100. A higher value represents a better outcome.

  3. Knee Society Score [outcome measure will be taken 6 weeks (± 2 weeks) postoperatively]

    Knee Society Score. The score is on a scale from 0-100. A higher value represents a better outcome.

  4. WOMAC Score [outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)]

    WOMAC score. The score is on a scale from 0-100. In contrast to the Knee Society Score, on the WOMAC a lower value represents a better outcome

  5. WOMAC Score [outcome measure will be taken 6 weeks (± 2 weeks) postoperatively]

    WOMAC score. The score is on a scale from 0-100. In contrast to the Knee Society Score, on the WOMAC a lower value represents a better outcome

  6. Active range-of-motion (ROM) [outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)]

    Active ROM (range-of-motion) as measured by a goniometer (range of 0-135 degrees)

  7. Active range-of-motion (ROM) [outcome measure will be taken 6 weeks (± 2 weeks) postoperatively]

    Active ROM (range-of-motion) as measured by a goniometer (range of 0-135 degrees)

  8. Incidence of loss of knee motion requiring an MUA (manipulation under anesthesia) [outcome measure will be taken 6 weeks (± 2 weeks) postoperatively]

    Loss of knee motion is defined as failure to achieve greater than 100 degrees of active flexion. Manipulation under anesthesia is an outpatient procedure performed by orthopedic surgeon to help improve patient's range-of-motion.

  9. Operative Time [outcome measure will be taken at 2 weeks postoperatively]

    Total Operative Time as defined in minutes

  10. Tourniquet time [outcome measure will be taken at 2 weeks postoperatively]

    Total Tourniquet Time is the number of minutes that the tourniquet is inflated, as defined in minutes.

  11. Estimated Blood Loss (EBL) [outcome measure will be taken at 2 weeks postoperatively]

    Estimated Blood Loss as defined by the amount of intraoperative blood loss measured in cubic centimeters (cc).

Secondary Outcome Measures

  1. Number of Participants with postoperative complications [outcome measure will be taken 6 weeks (± 2 weeks) postoperatively]

    Number of Participants with postoperative complications. A postoperative complication is defined as any diagnosis or condition that necessitates a re-operation or procedure on the surgical knee

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patient is between the age of 22-89

  2. Patient is scheduled to undergo a unilateral, cementless primary TKA, secondary to osteoarthritis

  3. Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization documents

  4. Patient is able to read and speak English.

Exclusion Criteria:
  1. Patient is under the age of 22 or over the age of 89

  2. Patient has preoperative stiffness/contracture of the knee secondary to post-traumatic arthritis

  3. Patient is scheduled to undergo a bilateral TKA surgery

  4. Patient is unable to read and speak English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jewish Hospital Louisville Kentucky United States 40202

Sponsors and Collaborators

  • University of Louisville

Investigators

  • Principal Investigator: Arthur Malkani, MD, University of Louisville

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Arthur Malkani, Professor, Adult Reconstruction, Dept. of Orthopaedic Surgery, University of Louisville
ClinicalTrials.gov Identifier:
NCT04217486
Other Study ID Numbers:
  • 19.1179
First Posted:
Jan 3, 2020
Last Update Posted:
Sep 16, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2021